Asahi Ito

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress

Masaki Ri, Shinsuke Iida, Takayuki Nakashima et al. · Leukemia · 2010 · 180 citations

Hematological Malignancy, Mutated Psmb5, Unfolded Proteins +7

Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing

Masaki Ri, Etsu Tashiro, Daisuke Oikawa et al. · Blood Cancer Journal · 2012 · 180 citations · Full text

Potent Inhibitor, Molecular Regulation, Molecular Biology +20

Stevens–Johnson <scp>S</scp>yndrome associated with mogamulizumab treatment of adult <scp>T</scp>‐cell leukemia / lymphoma

Takashi Ishida, Asahi Ito, Fumihiko Sato et al. · Cancer Science · 2013 · 128 citations · Full text

Immunology, Pathology, Regulatory T Cells +18

Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model

Asahi Ito, Takashi Ishida, Hiroki Yano et al. · Cancer Immunology Immunotherapy · 2008 · 126 citations · Full text

Cyclin-dependent kinase 9 is a novel specific molecular target in adult T-cell leukemia/lymphoma

Tomoko Narita, Takashi Ishida, Asahi Ito et al. · Blood · 2017 · 68 citations · Full text